Placeholder

Pioglitazone

CAS No:
111025-46-8 Categories: , ,
  • # LGM Pharma is a Pioglitazone CAS# 111025-46-8 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Pioglitazone
  • CAS #: 111025-46-8
  • Mode of Action:

    Pioglitazone acts as an agonist at peroxisome proliferator activated receptors (PPAR) in target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPAR-gamma receptors increases the transcription of insulin-responsive genes involved in the control of glucose production, transport, and utilization. In this way, pioglitazone both enhances tissue sensitivity to insulin and reduces hepatic gluconeogenesis. Thus, insulin resistance associated with type 2 diabetes mellitus is improved without an increase in insulin secretion by pancreatic _ cells.

  • Pharmacodynamics:

    Pioglitazone, a member of the drug group known as the thiazolidinediones or "insulin sensitizers", is not chemically or functionally related to the alpha-glucosidase inhibitors, the biguanides, or the sulfonylureas. Pioglitazone targets insulin resistance and, hence, is used alone or in combination with insulin, metformin, or asulfonylurea as an antidiabetic agent.

  • Metabolism:

    Hepatic

  • Toxicity:

    Hypogycemia; LD50=mg/kg (orally in rat)

  • IUPAC: 5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1, 3-thiazolidine-2, 4-dione
  • ATC: A10BG03
  • PubChem: 4829
  • DrugBank: DB01132 (APRD00653)
  • Formula: C10H17N3S
  • Molecular Mass: 356.439
  • Synonyms: Pioglitazona [INN-Spanish] Pioglitazone [Ban:Inn] pioglitazone HCl Pioglitazone Hydrochloride Pioglitazonum [INN-Latin]
  • SMILES: CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1
  • AHFS Code: 08:20.3
  • InChl: HYAFETHFCAUJAY-UHFFFAOYSA-N
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants

 

  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements
This website uses cookies. By using our site, you agree to our terms of service